- B3 reported a second-quarter net income of R$1.24 billion, which is an 18% increase year-over-year.
- The net income exceeded analyst estimates, which were R$1.19 billion.
- Capital expenditure for the quarter was R$43.5 million.
- Recurring net income for the quarter was R$1.23 billion, a 5% increase year-over-year.
- Analyst ratings include 8 buys, 9 holds, and no sells.
A look at B3 – Brasil Bolsa Balcao Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 5 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
“`html
Based on the Smartkarma Smart Scores, B3 – Brasil Bolsa Balcao shows a promising long-term outlook with a strong resilience score of 5, indicating its ability to weather market uncertainties and challenges. The company also scores well in terms of dividends and growth, with scores of 3 for both factors, suggesting a stable payout and potential for future development. Despite a slightly lower value score of 2, the overall outlook remains positive for B3 – Brasil Bolsa Balcao, supported by a decent momentum score of 3.
B3 S.A. – Brasil, Bolsa, Balcao operates as a regional exchange with an integrated business model that includes clearing and settlement activities, central depository services, and trading in equity, commodity, and derivatives. With a global reach, B3 S.A. – Brasil, Bolsa, Balcao serves a diverse range of customers, positioning itself as a key player in the financial market. The company’s solid resilience score, coupled with respectable scores in dividends, growth, and momentum, bodes well for its future performance and stability.
“`
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
